FF
DGX icon

FourThought Financial’s Quest Diagnostics DGX Stock Holding History

FourThought Financial’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Hold
10
– – ﹤0.01% 1397
2022
Q2 		$1K Hold
10
– – ﹤0.01% 1390
2022
Q1 		$1K Hold
10
– – ﹤0.01% 1392
2021
Q4 		$2K Hold
10
– – ﹤0.01% 1361
2021
Q3 		$1K Hold
10
– – ﹤0.01% 1434
2021
Q2 		$1K Hold
10
– – ﹤0.01% 1425
2021
Q1 		$1K Hold
10
– – ﹤0.01% 1388
2020
Q4 		$1K Buy
+10
New +$1.22K ﹤0.01% 1363

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FourThought Financial's DGX Position: Q3 2022 in Review

FourThought Financial held its Quest Diagnostics (DGX) position steady in Q3 2022 at 10 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1397.

FourThought Financial first reported a position in DGX in Q4 2020 and has held it in 8 quarters since. The position peaked at $2K in Q4 2021. 809 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • FourThought Financial held 10 shares of Quest Diagnostics worth $1K as of Q3 2022.
  • FourThought Financial left its Quest Diagnostics share count unchanged in Q3 2022.
  • Quest Diagnostics made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1397 holding.
  • FourThought Financial first reported a position in Quest Diagnostics in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's Quest Diagnostics position peaked at $2K in Q4 2021.
  • 809 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.